<unk>  is an alpha-1 adrenergic antagonist that is FDA approved for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).   Common adverse reactions include retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis, and nasal congestion.
Silodosin
Terazosin
Tilmicosin
Trimazosin
Doxazosin
Almitrine
Oxymetazoline
Moxaverine